Multidrug-resistant Pseudomonas aeruginosa skin and soft-tissue infection successfully treated with ceftolozane/tazobactam.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of global antimicrobial resistance"
DOI: 10.1016/j.jgar.2017.02.012
Abstract: Ceftolozane/tazobactam (C/T) is a novel β-lactam/β-lactamase inhibitor combination antibiotic approved by the US Food and Drug Administration for the treatment of complicated intra-abdominal and urinary tract infections due to Gram-negative bacteria, particularly extended-spectrum β-lactamase-producing Enterobacteriaceae… read more here.
Keywords: aeruginosa skin; skin soft; pseudomonas aeruginosa; soft tissue ... See more keywords